SPAIN | ACTIS
06/11/2019
Lmite 04 Dic 2020
Oferta Tecnolgica
Ref.
TOES20191129002
SHIP-1 inhibitors for prophylactic treatment and/or prevention of infectious diseases.
A Spanish research institution, in conjunction with two American universities, has discovered that the use of SHIP-1 inhibitors enhance the non-specific response of trained innate immune cells. This increased activity may offer an improved prophylactic treatment or prevention of subsequent infections by means of the enhancement of the memory and non-specific responses of trained innate immune cells. They are looking for partners, with not preferred location, to establish a license agreement.
Socios

logotipo CEOE Aragnlogotipo ITAINNOVAlogotipo Cmara Toledologotipo FEDAlogotipo UCLM
logotipo FUNDECYT-PCTEX logotipo ADERlogotipo FERlogotipo AINlogotipo UNAV

06/11/2019

Requerimientos: IE 6.0+, FF 1.5+ 1024x768+ | Aviso Legal | Confidencialidad

06/11/2019